国际皮肤性病学杂志    2002 28 (5): 306-309   ISSN: 2096-5540  CN: 32-1880/R   治疗淋病合并沙眼衣原体感染的药物选择 张尧, 吴小候 重庆医科大学附属第一医院, 400016 收稿日期 2001-12-25  修回日期 null  网络版发布日期 null 参考文献  [1] Robinson A J, Ridgway GL. Concurrent gonococcal and chlamydial infection;how best to treat. Drugs,2000,59(4):801-813. [2] Paavonen J, Eggert-Kruse W. Chlamydia trachomatis;impact on human reproduction. Hum Reprod Update, 1999,5(5):433-447. [3] FitzGerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS, 1996,7(4):298-300. [4] van Duynhoven YT. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect, 1999,1(6):455-464. [5] Aplasca De Los Reyes MR, Pato-Mesola V, Klausner JD, et al. A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines. Clin Infect Dis, 2001, 32(9):1313-1318. [6] Centers For Disease Control and Prevention. 2002 Guidelinse for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep,2002,51;No. RR-6. [7] Horner PJ, Cain D, McClure M, et al. Association of antibodies to Chlamydia trachomatis heat-shock protein 60 kD with chronic nongonococcal urethritis. Clin Infect Dis,1997,24(4):653-660. [8] Romanowski B, Talbot H, Stadnyk M, et al. Minocycline compared with doxycycline in the tieatment of nongonococcal urethritis and mucopurulent cervicitis. Ann Intern Med, 1993,119(1):16-22. [9] Mikamo H, Sato Y, Hayasaki Y, et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.Chemotherapy, 1999,45(5):396-398. [10] Radowicki S, Tyc M, Kulesza E, et al. Roxithromycin(Rulid) in treatment of Chlamydia trachomatis genital infections in women.Ginekol Pol, 1995,66(6):354-356. [11] Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sex Transm Dis,1994,21(2):107-111. [12] Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents.J Pediatr,1993,122(6):961-965. [13] Hillis SD, Coles FB, Litchfield B,et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis,1998, 25(1):5-11. [14] Lind I. Antimicrobial resistance in Neisseria gonorrhoeae. Clin Infect Dis,1997, 24(Suppl 1):S93-97. [15] Peipert JF, Sweet RL, Walker CK, et al. Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease(salpingitis). Infect Dis Obstet Gynecol, 1999,7(3):138-144. [16] Jones RB, Schwebke J, Thorpe EM Jr,et al. Randomized trial of tro-vafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group. Am J Med, 1998,104(1):28-32. [17] Moi H, Morel P, Gianotti B,et al. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. J Antimicrob Chemother, 1996,37(Suppl A):115-122. [18] Hook EW 3rd, McCormack WM, Martin D, et al. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group. Antimicrob Agents Chemother, 1997,41(8):1843-1845. [19] McCormack WM, Martin DH, Hook EW 3rd,et al. Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection. Infect Dis Obstet Gynecol, 1998,6(3):109-115. [20] Biedenbach DJ, Beach ML, Jones RN. Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains. Diagn Microbiol Infect Dis,1998,32(4):307-311. [21] No authors listed. Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Commun Dis Intell,1997,21(23):349-353. 通讯作者: